# A Study Assessing KB304 for the Treatment of Wrinkles in Women

> **NCT06724900** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Krystal Biotech, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Wrinkles in Decolletage
- Pigmentation
- Décolleté Wrinkles

## Interventions

- **BIOLOGICAL:** KB304
- **DRUG:** 0.9% Normal Saline (NS)

## Key facts

- **NCT ID:** NCT06724900
- **Lead sponsor:** Krystal Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2025-07
- **Final completion:** 2025-08
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724900, "A Study Assessing KB304 for the Treatment of Wrinkles in Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06724900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*